Industry Research Reports
Home > Reports > Chemical & Material > Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 143 Pages
Report ld: 6895195
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Bio-active Peptides was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
The North American market for Bio-active Peptides was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Bio-active Peptides was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Bio-active Peptides was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Bio-active Peptides market include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech, Naturade, Royal DSM, MYOS RENS Technology, Natural Factors Nutritional Products, Valio Oy, Wuhan Lullaby Pharmaceutical Chemical, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Bio-active Peptides, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Bio-active Peptides market size, estimations, and forecasts are presented in terms of sales volume (Ton) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Bio-active Peptides.
MARKET SEGMENTATION
By Company
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep
- Arlak Biotech
- Naturade
- Royal DSM
- MYOS RENS Technology
- Natural Factors Nutritional Products
- Valio Oy
- Wuhan Lullaby Pharmaceutical Chemical
- Wuhan Dahua Pharmaceutical
- Pharma Foods International
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Bio-active Peptides
- Artificial Synthesis Bio-active Peptides
Segment by Application
- Food
- Health Products
- Pharmaceutical
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Bio-active Peptides manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Bio-active Peptides sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Bio-active Peptides sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Bio-active Peptides Product Introduction
1.2 Global Bio-active Peptides Market Size Forecast
1.2.1 Global Bio-active Peptides Sales Value (2021–2032)
1.2.2 Global Bio-active Peptides Sales Volume (2021–2032)
1.2.3 Global Bio-active Peptides Sales Price (2021–2032)
1.3 Bio-active Peptides Market Trends & Drivers
1.3.1 Bio-active Peptides Industry Trends
1.3.2 Bio-active Peptides Market Drivers & Opportunities
1.3.3 Bio-active Peptides Market Challenges
1.3.4 Bio-active Peptides Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bio-active Peptides Players Revenue Ranking (2025)
2.2 Global Bio-active Peptides Revenue by Company (2021–2026)
2.3 Global Bio-active Peptides Sales Volume Ranking of Players (2025)
2.4 Global Bio-active Peptides Sales Volume by Company (2021–2026)
2.5 Global Bio-active Peptides Average Price by Company (2021–2026)
2.6 Key Manufacturers Bio-active Peptides Manufacturing Base and Headquarters
2.7 Key Manufacturers Bio-active Peptides Product Offerings
2.8 Key Manufacturers Start of Mass Production of Bio-active Peptides
2.9 Bio-active Peptides Market Competitive Analysis
2.9.1 Bio-active Peptides Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Bio-active Peptides Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bio-active Peptides revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Bio-active Peptides Market Classification
3.1 Introduction by Type
3.1.1 Natural Bio-active Peptides
3.1.2 Artificial Synthesis Bio-active Peptides
3.1.3 Global Bio-active Peptides Sales Value by Type
3.1.3.1 Global Bio-active Peptides Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Bio-active Peptides Sales Value, by Type (2021–2032)
3.1.3.3 Global Bio-active Peptides Sales Value, by Type (%), 2021–2032
3.1.4 Global Bio-active Peptides Sales Volume by Type
3.1.4.1 Global Bio-active Peptides Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Bio-active Peptides Sales Volume, by Type (2021–2032)
3.1.4.3 Global Bio-active Peptides Sales Volume, by Type (%), 2021–2032
3.1.5 Global Bio-active Peptides Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food
4.1.2 Health Products
4.1.3 Pharmaceutical
4.1.4 Other
4.2 Global Bio-active Peptides Sales Value by Application
4.2.1 Global Bio-active Peptides Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Bio-active Peptides Sales Value, by Application (2021–2032)
4.2.3 Global Bio-active Peptides Sales Value, by Application (%), 2021–2032
4.3 Global Bio-active Peptides Sales Volume by Application
4.3.1 Global Bio-active Peptides Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Bio-active Peptides Sales Volume, by Application (2021–2032)
4.3.3 Global Bio-active Peptides Sales Volume, by Application (%), 2021–2032
4.4 Global Bio-active Peptides Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Bio-active Peptides Sales Value by Region
5.1.1 Global Bio-active Peptides Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Bio-active Peptides Sales Value by Region (2021–2026)
5.1.3 Global Bio-active Peptides Sales Value by Region (2027–2032)
5.1.4 Global Bio-active Peptides Sales Value by Region (%), 2021–2032
5.2 Global Bio-active Peptides Sales Volume by Region
5.2.1 Global Bio-active Peptides Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Bio-active Peptides Sales Volume by Region (2021–2026)
5.2.3 Global Bio-active Peptides Sales Volume by Region (2027–2032)
5.2.4 Global Bio-active Peptides Sales Volume by Region (%), 2021–2032
5.3 Global Bio-active Peptides Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Bio-active Peptides Sales Value, 2021–2032
5.4.2 North America Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Bio-active Peptides Sales Value, 2021–2032
5.5.2 Europe Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Bio-active Peptides Sales Value, 2021–2032
5.6.2 Asia Pacific Bio-active Peptides Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Bio-active Peptides Sales Value, 2021–2032
5.7.2 South America Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bio-active Peptides Sales Value, 2021–2032
5.8.2 Middle East & Africa Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bio-active Peptides Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Bio-active Peptides Sales Value and Sales Volume
6.2.1 Key Countries/Regions Bio-active Peptides Sales Value, 2021–2032
6.2.2 Key Countries/Regions Bio-active Peptides Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Bio-active Peptides Sales Value, 2021–2032
6.3.2 United States Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Bio-active Peptides Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Bio-active Peptides Sales Value, 2021–2032
6.4.2 Europe Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Bio-active Peptides Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Bio-active Peptides Sales Value, 2021–2032
6.5.2 China Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
6.5.3 China Bio-active Peptides Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Bio-active Peptides Sales Value, 2021–2032
6.6.2 Japan Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Bio-active Peptides Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Bio-active Peptides Sales Value, 2021–2032
6.7.2 South Korea Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Bio-active Peptides Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Bio-active Peptides Sales Value, 2021–2032
6.8.2 Southeast Asia Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Bio-active Peptides Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Bio-active Peptides Sales Value, 2021–2032
6.9.2 India Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
6.9.3 India Bio-active Peptides Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Archer Daniels Midland Company
7.1.1 Archer Daniels Midland Company Company Information
7.1.2 Archer Daniels Midland Company Introduction and Business Overview
7.1.3 Archer Daniels Midland Company Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Archer Daniels Midland Company Bio-active Peptides Product Offerings
7.1.5 Archer Daniels Midland Company Recent Developments
7.2 Seagarden AS
7.2.1 Seagarden AS Company Information
7.2.2 Seagarden AS Introduction and Business Overview
7.2.3 Seagarden AS Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Seagarden AS Bio-active Peptides Product Offerings
7.2.5 Seagarden AS Recent Developments
7.3 Phermpep
7.3.1 Phermpep Company Information
7.3.2 Phermpep Introduction and Business Overview
7.3.3 Phermpep Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Phermpep Bio-active Peptides Product Offerings
7.3.5 Phermpep Recent Developments
7.4 Arlak Biotech
7.4.1 Arlak Biotech Company Information
7.4.2 Arlak Biotech Introduction and Business Overview
7.4.3 Arlak Biotech Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Arlak Biotech Bio-active Peptides Product Offerings
7.4.5 Arlak Biotech Recent Developments
7.5 Naturade
7.5.1 Naturade Company Information
7.5.2 Naturade Introduction and Business Overview
7.5.3 Naturade Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Naturade Bio-active Peptides Product Offerings
7.5.5 Naturade Recent Developments
7.6 Royal DSM
7.6.1 Royal DSM Company Information
7.6.2 Royal DSM Introduction and Business Overview
7.6.3 Royal DSM Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Royal DSM Bio-active Peptides Product Offerings
7.6.5 Royal DSM Recent Developments
7.7 MYOS RENS Technology
7.7.1 MYOS RENS Technology Company Information
7.7.2 MYOS RENS Technology Introduction and Business Overview
7.7.3 MYOS RENS Technology Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 MYOS RENS Technology Bio-active Peptides Product Offerings
7.7.5 MYOS RENS Technology Recent Developments
7.8 Natural Factors Nutritional Products
7.8.1 Natural Factors Nutritional Products Company Information
7.8.2 Natural Factors Nutritional Products Introduction and Business Overview
7.8.3 Natural Factors Nutritional Products Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Natural Factors Nutritional Products Bio-active Peptides Product Offerings
7.8.5 Natural Factors Nutritional Products Recent Developments
7.9 Valio Oy
7.9.1 Valio Oy Company Information
7.9.2 Valio Oy Introduction and Business Overview
7.9.3 Valio Oy Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Valio Oy Bio-active Peptides Product Offerings
7.9.5 Valio Oy Recent Developments
7.10 Wuhan Lullaby Pharmaceutical Chemical
7.10.1 Wuhan Lullaby Pharmaceutical Chemical Company Information
7.10.2 Wuhan Lullaby Pharmaceutical Chemical Introduction and Business Overview
7.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Offerings
7.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Developments
7.11 Wuhan Dahua Pharmaceutical
7.11.1 Wuhan Dahua Pharmaceutical Company Information
7.11.2 Wuhan Dahua Pharmaceutical Introduction and Business Overview
7.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Wuhan Dahua Pharmaceutical Bio-active Peptides Product Offerings
7.11.5 Wuhan Dahua Pharmaceutical Recent Developments
7.12 Pharma Foods International
7.12.1 Pharma Foods International Company Information
7.12.2 Pharma Foods International Introduction and Business Overview
7.12.3 Pharma Foods International Bio-active Peptides Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Pharma Foods International Bio-active Peptides Product Offerings
7.12.5 Pharma Foods International Recent Developments
8 Industry Chain Analysis
8.1 Bio-active Peptides Industrial Chain
8.2 Bio-active Peptides Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Bio-active Peptides Sales Model
8.5.2 Sales Channels
8.5.3 Bio-active Peptides Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Bio-active Peptides Market Trends
Table 2. Bio-active Peptides Market Drivers & Opportunities
Table 3. Bio-active Peptides Market Challenges
Table 4. Bio-active Peptides Market Restraints
Table 5. Global Bio-active Peptides Revenue by Company (US$ Million), 2021–2026
Table 6. Global Bio-active Peptides Revenue Market Share by Company (2021–2026)
Table 7. Global Bio-active Peptides Sales Volume by Company (Ton), 2021–2026
Table 8. Global Bio-active Peptides Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Bio-active Peptides Price by Company (US$/Ton), 2021–2026
Table 10. Key Manufacturers Bio-active Peptides Manufacturing Base and Headquarters
Table 11. Key Manufacturers Bio-active Peptides Product Type
Table 12. Key Manufacturers Start of Mass Production of Bio-active Peptides
Table 13. Global Bio-active Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Bio-active Peptides revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Bio-active Peptides Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Bio-active Peptides Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Bio-active Peptides Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Bio-active Peptides Sales Market Share in Value by Type (2021–2026)
Table 20. Global Bio-active Peptides Sales Market Share in Value by Type (2027–2032)
Table 21. Global Bio-active Peptides Sales Volume by Type: 2021 vs 2025 vs 2032 (Ton)
Table 22. Global Bio-active Peptides Sales Volume by Type (Ton), 2021–2026
Table 23. Global Bio-active Peptides Sales Volume by Type (Ton), 2027–2032
Table 24. Global Bio-active Peptides Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Bio-active Peptides Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Bio-active Peptides Price by Type (US$/Ton), 2021–2026
Table 27. Global Bio-active Peptides Price by Type (US$/Ton), 2027–2032
Table 28. Global Bio-active Peptides Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Bio-active Peptides Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Bio-active Peptides Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Bio-active Peptides Sales Market Share in Value by Application (2021–2026)
Table 32. Global Bio-active Peptides Sales Market Share in Value by Application (2027–2032)
Table 33. Global Bio-active Peptides Sales Volume by Application: 2021 vs 2025 vs 2032 (Ton)
Table 34. Global Bio-active Peptides Sales Volume by Application (Ton), 2021–2026
Table 35. Global Bio-active Peptides Sales Volume by Application (Ton), 2027–2032
Table 36. Global Bio-active Peptides Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Bio-active Peptides Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Bio-active Peptides Price by Application (US$/Ton), 2021–2026
Table 39. Global Bio-active Peptides Price by Application (US$/Ton), 2027–2032
Table 40. Global Bio-active Peptides Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Bio-active Peptides Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Bio-active Peptides Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Bio-active Peptides Sales Value by Region (%), 2021–2026
Table 44. Global Bio-active Peptides Sales Value by Region (%), 2027–2032
Table 45. Global Bio-active Peptides Sales Volume by Region (Ton): 2021 vs 2025 vs 2032
Table 46. Global Bio-active Peptides Sales Volume by Region (Ton), 2021–2026
Table 47. Global Bio-active Peptides Sales Volume by Region (Ton), 2027–2032
Table 48. Global Bio-active Peptides Sales Volume by Region (%), 2021–2026
Table 49. Global Bio-active Peptides Sales Volume by Region (%), 2027–2032
Table 50. Global Bio-active Peptides Average Price by Region (US$/Ton), 2021–2026
Table 51. Global Bio-active Peptides Average Price by Region (US$/Ton), 2027–2032
Table 52. Key Countries/Regions Bio-active Peptides Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Bio-active Peptides Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Bio-active Peptides Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Bio-active Peptides Sales Volume, (Ton), 2021–2026
Table 56. Key Countries/Regions Bio-active Peptides Sales Volume, (Ton), 2027–2032
Table 57. Archer Daniels Midland Company Company Information
Table 58. Archer Daniels Midland Company Introduction and Business Overview
Table 59. Archer Daniels Midland Company Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 60. Archer Daniels Midland Company Bio-active Peptides Product Offerings
Table 61. Archer Daniels Midland Company Recent Developments
Table 62. Seagarden AS Company Information
Table 63. Seagarden AS Introduction and Business Overview
Table 64. Seagarden AS Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 65. Seagarden AS Bio-active Peptides Product Offerings
Table 66. Seagarden AS Recent Developments
Table 67. Phermpep Company Information
Table 68. Phermpep Introduction and Business Overview
Table 69. Phermpep Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 70. Phermpep Bio-active Peptides Product Offerings
Table 71. Phermpep Recent Developments
Table 72. Arlak Biotech Company Information
Table 73. Arlak Biotech Introduction and Business Overview
Table 74. Arlak Biotech Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 75. Arlak Biotech Bio-active Peptides Product Offerings
Table 76. Arlak Biotech Recent Developments
Table 77. Naturade Company Information
Table 78. Naturade Introduction and Business Overview
Table 79. Naturade Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 80. Naturade Bio-active Peptides Product Offerings
Table 81. Naturade Recent Developments
Table 82. Royal DSM Company Information
Table 83. Royal DSM Introduction and Business Overview
Table 84. Royal DSM Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 85. Royal DSM Bio-active Peptides Product Offerings
Table 86. Royal DSM Recent Developments
Table 87. MYOS RENS Technology Company Information
Table 88. MYOS RENS Technology Introduction and Business Overview
Table 89. MYOS RENS Technology Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 90. MYOS RENS Technology Bio-active Peptides Product Offerings
Table 91. MYOS RENS Technology Recent Developments
Table 92. Natural Factors Nutritional Products Company Information
Table 93. Natural Factors Nutritional Products Introduction and Business Overview
Table 94. Natural Factors Nutritional Products Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 95. Natural Factors Nutritional Products Bio-active Peptides Product Offerings
Table 96. Natural Factors Nutritional Products Recent Developments
Table 97. Valio Oy Company Information
Table 98. Valio Oy Introduction and Business Overview
Table 99. Valio Oy Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 100. Valio Oy Bio-active Peptides Product Offerings
Table 101. Valio Oy Recent Developments
Table 102. Wuhan Lullaby Pharmaceutical Chemical Company Information
Table 103. Wuhan Lullaby Pharmaceutical Chemical Introduction and Business Overview
Table 104. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 105. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Offerings
Table 106. Wuhan Lullaby Pharmaceutical Chemical Recent Developments
Table 107. Wuhan Dahua Pharmaceutical Company Information
Table 108. Wuhan Dahua Pharmaceutical Introduction and Business Overview
Table 109. Wuhan Dahua Pharmaceutical Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 110. Wuhan Dahua Pharmaceutical Bio-active Peptides Product Offerings
Table 111. Wuhan Dahua Pharmaceutical Recent Developments
Table 112. Pharma Foods International Company Information
Table 113. Pharma Foods International Introduction and Business Overview
Table 114. Pharma Foods International Bio-active Peptides Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 115. Pharma Foods International Bio-active Peptides Product Offerings
Table 116. Pharma Foods International Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Key Suppliers of Raw Materials Lists
Table 119. Bio-active Peptides Downstream Customers
Table 120. Bio-active Peptides Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-active Peptides Product Picture
Figure 2. Global Bio-active Peptides Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 4. Global Bio-active Peptides Sales Volume (Ton), 2021–2032
Figure 5. Global Bio-active Peptides Sales Price (US$/Ton), 2021–2032
Figure 6. Bio-active Peptides Report Years Considered
Figure 7. Global Bio-active Peptides Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Bio-active Peptides Sales Volume Ranking of Players (Ton), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bio-active Peptides Revenue in 2025
Figure 10. Bio-active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Natural Bio-active Peptides Picture
Figure 12. Artificial Synthesis Bio-active Peptides Picture
Figure 13. Global Bio-active Peptides Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Bio-active Peptides Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Bio-active Peptides Sales Volume by Type (Ton), 2021 vs 2025 vs 2032
Figure 16. Global Bio-active Peptides Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Bio-active Peptides Price by Type (US$/Ton), 2021–2032
Figure 18. Product Picture of Food
Figure 19. Product Picture of Health Products
Figure 20. Product Picture of Pharmaceutical
Figure 21. Product Picture of Other
Figure 22. Global Bio-active Peptides Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Bio-active Peptides Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Bio-active Peptides Sales Volume by Application (Ton), 2021 vs 2025 vs 2032
Figure 25. Global Bio-active Peptides Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Bio-active Peptides Price by Application (US$/Ton), 2021–2032
Figure 27. North America Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 28. North America Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 30. Europe Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Bio-active Peptides Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 34. South America Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Bio-active Peptides Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Bio-active Peptides Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Bio-active Peptides Sales Volume (%), 2021–2032
Figure 39. United States Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 40. United States Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Bio-active Peptides Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 43. Europe Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Bio-active Peptides Sales Value by Application (%), 2025 vs 2032
Figure 45. China Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 46. China Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
Figure 47. China Bio-active Peptides Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 49. Japan Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Bio-active Peptides Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Bio-active Peptides Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Bio-active Peptides Sales Value by Application (%), 2025 vs 2032
Figure 57. India Bio-active Peptides Sales Value (US$ Million), 2021–2032
Figure 58. India Bio-active Peptides Sales Value by Type (%), 2025 vs 2032
Figure 59. India Bio-active Peptides Sales Value by Application (%), 2025 vs 2032
Figure 60. Bio-active Peptides Industrial Chain
Figure 61. Bio-active Peptides Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Bio-active Peptides market?
The top companies in the global Bio-active Peptides market are Archer Daniels Midland Company、Seagarden AS、Phermpep.
Related Reports
Global Bio-active Peptides Market Research Report 2026
The global Bio-active Peptides market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 136
USD 2900.00
(Single User License)
Global Bio-active Peptides Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bio-active Peptides market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 157
USD 4900.00
(Single User License)
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-active Peptides was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 114
USD 3950.00
(Single User License)
Global Bio-active Peptides Market Research Report 2025
The global market for Bio-active Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 96
USD 2900.00
(Single User License)
Global Bio-active Peptides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-active Peptides market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 91
USD 4250.00
(Single User License)
Global Bio-active Peptides Market Insights, Forecast to 2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-04-08
Pages: 113
USD 4900.00
(Single User License)
Bio-active Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-02-22
Pages: 122
USD 3950.00
(Single User License)
Global Bio-active Peptides Market Research Report 2024
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-01-16
Pages: 100
USD 2900.00
(Single User License)
Global Bio-active Peptides Market Research Report 2026
The global Bio-active Peptides market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 136
USD 2900.00 (Single User License)Global Bio-active Peptides Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bio-active Peptides market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 157
USD 4900.00 (Single User License)Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-active Peptides was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 114
USD 3950.00 (Single User License)Global Bio-active Peptides Market Research Report 2025
The global market for Bio-active Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 96
USD 2900.00 (Single User License)Global Bio-active Peptides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-active Peptides market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 91
USD 4250.00 (Single User License)Global Bio-active Peptides Market Insights, Forecast to 2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-04-08
Pages: 113
USD 4900.00 (Single User License)Bio-active Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-02-22
Pages: 122
USD 3950.00 (Single User License)Global Bio-active Peptides Market Research Report 2024
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-01-16
Pages: 100
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now